Fuster V - Search Results

1

Fernández-Ortiz A, Jang IK, Fuster V. Fernández-Ortiz A, et al. Among authors: fuster v. Coron Artery Dis. 1994 Apr;5(4):297-305. doi: 10.1097/00019501-199404000-00005. Coron Artery Dis. 1994. PMID: 8044341 Review. No abstract available.

2

Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.

Meyer BJ, Badimon JJ, Mailhac A, Fernández-Ortiz A, Chesebro JH, Fuster V, Badimon L. Meyer BJ, et al. Among authors: fuster v. Circulation. 1994 Nov;90(5):2432-8. doi: 10.1161/01.cir.90.5.2432. Circulation. 1994. PMID: 7955200

3

Atherogenesis and inflammation.

Jang IK, Lassila R, Fuster V. Jang IK, et al. Among authors: fuster v. Eur Heart J. 1993 Dec;14 Suppl K:2-6. Eur Heart J. 1993. PMID: 8131783 Review.

4

Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.

Mailhac A, Badimon JJ, Fallon JT, Fernández-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L. Mailhac A, et al. Among authors: fuster v. Circulation. 1994 Aug;90(2):988-96. doi: 10.1161/01.cir.90.2.988. Circulation. 1994. PMID: 8044972

5

A new approach for local intravascular drug delivery. Iontophoretic balloon.

Fernández-Ortiz A, Meyer BJ, Mailhac A, Falk E, Badimon L, Fallon JT, Fuster V, Chesebro JH, Badimon JJ. Fernández-Ortiz A, et al. Among authors: fuster v. Circulation. 1994 Apr;89(4):1518-22. doi: 10.1161/01.cir.89.4.1518. Circulation. 1994. PMID: 8149516

6

Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture.

Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Fernández-Ortiz A, et al. Among authors: fuster v. J Am Coll Cardiol. 1994 Jun;23(7):1562-9. doi: 10.1016/0735-1097(94)90657-2. J Am Coll Cardiol. 1994. PMID: 8195515 Free article.

7

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty.

Smith AJ, Holt RE, Fitzpatrick JB, Palacios IF, Gold HK, Werner W, Bovill EG, Fuster V, Jang IK. Smith AJ, et al. Among authors: fuster v. Am Heart J. 1996 Mar;131(3):434-9. doi: 10.1016/s0002-8703(96)90520-7. Am Heart J. 1996. PMID: 8604621

8

Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease.

Falk E, Fallon JT, Mailhac A, Fernandez-Ortiz A, Meyer BJ, Weng D, Shah PK, Badimon JJ, Fuster V. Falk E, et al. Among authors: fuster v. Cardiovasc Pathol. 1994 Jul-Sep;3(3):183-9. doi: 10.1016/1054-8807(94)90028-0. Cardiovasc Pathol. 1994. PMID: 25990995

9

Expanded use of thrombolytic therapy.

Curwin J, Jang IK, Fuster V. Curwin J, et al. Among authors: fuster v. Mayo Clin Proc. 1992 Oct;67(10):1004-5. doi: 10.1016/s0025-6196(12)60934-3. Mayo Clin Proc. 1992. PMID: 1434847 No abstract available.

10

Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.

Meyer BJ, Fernández-Ortiz A, Mailhac A, Falk E, Badimon L, Michael AD, Chesebro JH, Fuster V, Badimon JJ. Meyer BJ, et al. Among authors: fuster v. Circulation. 1994 Nov;90(5):2474-80. doi: 10.1161/01.cir.90.5.2474. Circulation. 1994. PMID: 7955205

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,572 results

Search Page